Abstract:
The present invention relates generally to a population of cells genetically modified to express a detectable marker of fenestration and uses thereof. The cells of the present invention are useful in a wide variety of applications, in particular in the context of in vitro based screening systems for testing the effectiveness and/or toxicity of potential therapeutic or prophylactic treatment regimes.